Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
AZN
ASTRAZENECA PLC
NYSE
$163.78
▲ UP 2.25% (3.61)

KEY STATISTICS

Market Cap$248.40 B
52w High$212.71
52w Low$145.80
Dividend Yield1.21%
FrequencySemi-Annual
P/E17.69
Volume3.09M
Shares Out.1.55B

COMPANY

LEADERSHIP

Pascal Claude Roland Soriot
CHIEF EXECUTIVE
Pascal Claude Roland Soriot

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 12, 1993
METHOD OF GOING PUBLIC
Dual Listing
FULL TIME EMPLOYEES
96,100

PRICE TARGET

Target High$216.00
Target Low$158.00
Target Median$185.00
Target Consensus$186.67

UPCOMING EARNINGS

DateOct 30, 2026
DayFriday
Rev. Est.$16.06B
OCT
30
FRI

SPLIT RECORD

DATETYPERATIO
2026-02-02Reverse1:2
2015-07-27Forward2:1
1998-04-08Forward3:1

PRICE

$163.78 ▲ UP 2.25% (+$3.61)
OVERLAYS
$163$164$1649:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM163.78

About AstraZeneca PLC

https://www.astrazeneca.com ↗

AstraZeneca PLC is a global biopharmaceutical company developing and commercializing medicines for cardiovascular, oncology, and rare diseases, with a broad portfolio and collaborations in drug discovery and AI technologies.

INDUSTRY

Drug Manufacturers - General

A PRODUCT ASTRAZENECA PLC IS KNOWN FOR

Tagrisso (osimertinib)
Tagrisso (osimertinib)

Tagrisso, a targeted therapy for genetically mutated non-small cell lung cancer, is a key AstraZeneca oncology product, driving revenue and establishing itself as a standard of care in innovative cancer treatment.

COMPETITORS

COMPETITOR
BMY COMPARE
JNJ COMPARE
LLY COMPARE
MRK COMPARE
PFE COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
130
LISTED HERE
26
RANKED BY POSITION SIZE
SPDW
0.72% · 1.9M
DIHP
0.88% · 356.7K
IHDG
2.16% · 289.2K
TPE.TO
1.04% · 269.3K
CBUF.F
4.37% · 266.0K
PPH
3.64% · 227.3K
PIEQ
2.61% · 226.8K
FCIQ.TO
2.26% · 205.4K
FVD
0.41% · 205.2K
SCRD
0.45% · 139.0K
JDVI
2.51% · 121.0K
IDVO
1.07% · 96.8K
TXUE
2.69% · 93.1K
PXF
0.44% · 83.4K
APIE
1.00% · 71.9K
HXDM.TO
1.10% · 64.6K
AFTY
1.60% · 56.1K
RG
RGEF
0.83% · 42.4K
IDVZ
2.83% · 35.5K
CN
CNCR
3.39% · 26.5K
DBLV
2.93% · 22.0K
SW
SWP
2.25% · 20.8K
SPWO
1.22% · 17.2K
NUSI
0.24% · 12.5K
OZEM
3.36% · 12.2K
AZNH
99.33% · 11.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
25.87%
HOLDERS
2,106
TOP 12 OF 2,106 · RANKED BY POSITION SIZE
Investor Ab
51.6M sh · $10.17B
Price T Rowe Associates Inc /Md/
49.1M sh · $3.77B
Primecap Management Co/Ca/
39.9M sh · $3.06B
Capital International Investors
34.6M sh · $6.49B
Norges Bank
33.9M sh · $6.33B
Bank Of America Corp /De/
32.6M sh · $2.5B
Wellington Management Group Llp
32.3M sh · $2.48B
Capital World Investors
30.1M sh · $5.63B
Fmr LLC
29.6M sh · $5.8B
Legal & General Group Plc
25.8M sh · $5.01B
Fisher Asset Management, LLC
21.6M sh · $1.99B
Franklin Resources Inc
20.2M sh · $1.85B

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2025-12-18
 Gilbert Ray Cisneros
Gilbert Ray Cisneros
Purchase
2025-12-18
 Julia Letlow
Julia Letlow
Purchase
2025-12-08
 Lisa McClain
Lisa McClain
Sale
2025-10-31

INSIDER TRADES

★
OFFICER: SEE REMARKS
Sharma Mani
Purchase · 1 shares
2026-09-08
★
OFFICER: SEE REMARKS
Sharma Mani
Purchase · 20 shares
2026-08-08
★
OFFICER: SVP, GROUP CONTROLLER
Sharma Mani
Purchase · 2 shares
2026-08-06
★
OFFICER: SEE REMARKS
Sharma Mani
Purchase · 2 shares
2026-07-06

SECTORS PEERS

PEERPRICE
LLY$1143.60COMPARE
JNJ$267.68COMPARE
ABBV$261.28COMPARE
MRK$145.36COMPARE
NVS$139.65COMPARE
AMGN$379.56COMPARE
GILD$145.33COMPARE
PFE$27.75COMPARE